Availability and financing of CAR-T cell therapies: A cross-country comparative analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Health Policy (149:) - Amsterdam : Elsevier - Art.-Id. 105153
- Event
-
Veröffentlichung
- (where)
-
Berlin
- (who)
-
Technische Universität Berlin
- (when)
-
2024
- Creator
-
Litvinova, Yulia
Merkur, Sherry
Allin, Sara
Angulo-Pueyo, Ester
Behmane, Daiga
Bernal-Delgado, Enrique
Dalmas, Miriam
De Belvis, Antonio
Edwards, Nigel
Estupiñán-Romero, Francisco
Gaal, Peter
Gerkens, Sophie
Jamieson, Margaret
Morsella, Alisha
Picecchi, Dario
Røshol, Hilde
Saunes, Ingrid Sperre
Sullivan, Terry
Szécsényi-Nagy, Balázs
Vijver, Inneke Van De
Walter, Ricciardi
Panteli, Dimitra
- DOI
-
10.14279/depositonce-21406
- Handle
-
11303/22605
- URN
-
urn:nbn:de:101:1-2409250157273.626909376605
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Litvinova, Yulia
- Merkur, Sherry
- Allin, Sara
- Angulo-Pueyo, Ester
- Behmane, Daiga
- Bernal-Delgado, Enrique
- Dalmas, Miriam
- De Belvis, Antonio
- Edwards, Nigel
- Estupiñán-Romero, Francisco
- Gaal, Peter
- Gerkens, Sophie
- Jamieson, Margaret
- Morsella, Alisha
- Picecchi, Dario
- Røshol, Hilde
- Saunes, Ingrid Sperre
- Sullivan, Terry
- Szécsényi-Nagy, Balázs
- Vijver, Inneke Van De
- Walter, Ricciardi
- Panteli, Dimitra
- Technische Universität Berlin
Time of origin
- 2024
Other Objects (12)
CAR-T cell combination therapies in hematologic malignancies
CAR-T Therapies in Solid Tumors: Opportunities and Challenges
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Disparities in Clinical Trial Enrollment– Focus on CAR-T and Bispecific Antibody Therapies
"CARt*"
CARt
CART
"CARt*
CARt
"CARt*
CAR-T cell combination therapies in hematologic malignancies
CAR-T Therapies in Solid Tumors: Opportunities and Challenges
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Disparities in Clinical Trial Enrollment– Focus on CAR-T and Bispecific Antibody Therapies
"CARt*"
CARt
CART
"CARt*
CARt
"CARt*
CAR-T cell combination therapies in hematologic malignancies
CAR-T Therapies in Solid Tumors: Opportunities and Challenges
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Disparities in Clinical Trial Enrollment– Focus on CAR-T and Bispecific Antibody Therapies
"CARt*"
CARt
CART
"CARt*
CARt